REZILIENT3: Phase 3 study of zipalertinib plus chemotherapy in patients with previously untreated, advanced nonsquamous non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertions (ex20ins) mutations

被引：0
|
作者：
Yu, Helena Alexandra
Besse, Benjamin
Nishio, Makoto
Cheng, Ying
Wei, Li
Wacheck, Volker
Heymach, John
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Inst Gustave Roussy, Villejuif, France
[3] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[4] Jilin Canc Hosp, Changchun, Peoples R China
[5] Taiho Oncol Inc, Princeton, NJ USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8671
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical Outcomes in Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring Rare Epidermal Growth Factor Receptor (EGFR) Mutations
    Domingues, Pedro M.
    Montella, Tatiane
    Zukin, Mauro
    Baldotto, Clarissa
    Ferreira, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S206 - S207
  • [32] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    APMIS, 2012, 120 : 14 - 14
  • [33] Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations
    Wu, Jenn-Yu
    Yu, Chong-Jen
    Shih, Jin-Yuan
    CLINICAL LUNG CANCER, 2019, 20 (06) : E620 - E630
  • [34] Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
    Yusuke Inoue
    Naoki Inui
    Kazuhiro Asada
    Masato Karayama
    Hiroyuki Matsuda
    Koshi Yokomura
    Naoki Koshimizu
    Shiro Imokawa
    Takashi Yamada
    Toshihiro Shirai
    Norio Kasamatsu
    Takafumi Suda
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 155 - 161
  • [35] Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
    Inoue, Yusuke
    Inui, Naoki
    Asada, Kazuhiro
    Karayama, Masato
    Matsuda, Hiroyuki
    Yokomura, Koshi
    Koshimizu, Naoki
    Imokawa, Shiro
    Yamada, Takashi
    Shirai, Toshihiro
    Kasamatsu, Norio
    Suda, Takafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 155 - 161
  • [36] Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Tokito, T.
    Ko, R.
    Imamura, C.
    Shukuya, T.
    Shimada, N.
    Koyama, R.
    Yamada, K.
    Ishii, H.
    Azuma, K.
    Takahashi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S565 - S565
  • [37] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Real-World (RW) frontline (1L) treatments (Txs) in patients (Pts) with advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EFGR) exon 20 insertions (exon20ins) and adjusted comparisons versus PAPILLON study
    Chouaid, C.
    Bosquet, L.
    Knott, C.
    Li, Z.
    Schaeffer, M.
    Lin, X.
    Schioppa, C.
    Perualila, N.
    Diels, J.
    Quintero, E.
    Galea, F.
    Hulten, A.
    Greystoke, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1650 - S1650
  • [39] RELAY plus : Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (NSCLC).
    Nishio, Makoto
    Nishio, Kazuto
    Reck, Martin
    Garon, Edward B.
    Imamura, Fumio
    Kawaguchi, Tomoya
    Yamaguchi, Hiroyuki
    Ikeda, Satoshi
    Hirano, Katsuya
    Visseren-Grul, Carla M.
    Widau, Ryan C.
    Zimmermann, Annamaria H.
    Homma, Gosuke
    Enatsu, Sotaro
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
    Hyun Sun Woo
    Hee Kyung Ahn
    Ha Yeon Lee
    Inkeun Park
    Young Saing Kim
    Junshik Hong
    Sun Jin Sym
    Jinny Park
    Jae Hoon Lee
    Dong Bok Shin
    Eun Kyung Cho
    Investigational New Drugs, 2014, 32 : 1311 - 1315
12345